Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06769022 · ClinicalTrials.gov registry record · NA
Exercise Adherence and Cognitive Decline
A NA study of Cognitive Decline, sponsored by University of Colorado, Boulder.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 3
- Study locations
NCT06769022: Recruiting NA study of Cognitive Decline, sponsored by University of Colorado, Boulder.
NCT06769022 is a NA study of Cognitive Decline that is actively recruiting participants, run by University of Colorado, Boulder. The registered enrollment target is 20 participants, below the 1,149-participant average among 61 other Cognitive Decline trials with a reported enrollment target (98% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06769022, a NA study of Cognitive Decline, is actively recruiting participants, sponsored by University of Colorado, Boulder.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to conduct a small-scale test of a goals-based program to help people to exercise more and learn what people like or don't like about the procedures. This program is being designed for individuals aged 45-65 from the Black community. Low levels of physical activity are related to health problems such as heart disease, diabetes, and cognitive decline. People of color are more negatively impacted by these conditions and have also historically been underrepresented by research seeking to increase physical activity. The investigators have developed this goals-based exercise promotion program with the help of a Black-led community-based organization (The Gyedi Project) and a Community Advisory Board made up of stakeholders in the Black community, and now the investigators are conducting a trial of its feasibility and acceptability.
Primary Outcome
Blood pressure of all participants is collected before intervention
Conditions Studied
Interventions
- BEHAVIORAL Goal Setting and Exercise Intensity Intervention
Study Locations (3)
Colorado
- Aurora Center for Active Adults - Aurora
- University of Colorado at Boulder - Boulder
- Hiawatha Davis Jr. Recreation Center - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-10-01 |
| Est. Completion | 2027-06-30 |
| Phase | NA |
What NCT06769022 shows while recruiting
NCT06769022 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,149-participant average among 61 other Cognitive Decline trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Cognitive Decline appearing as the primary indexed condition, and to 1 intervention - of which Goal Setting and Exercise Intensity Intervention is the first listed.
NCT06769022 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT06769022 about?
NCT06769022 is a clinical study titled "Exercise Adherence and Cognitive Decline". The purpose of this study is to conduct a small-scale test of a goals-based program to help people to exercise more and learn what people like or don't like about the procedures. This program is being designed for individuals aged 45-65 from the Black community. Low levels of physical activity are r...
What is the current status of trial NCT06769022?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2024-10-01. Estimated completion is 2027-06-30.
What conditions does trial NCT06769022 study?
This clinical trial studies the following conditions: Cognitive Decline.
What interventions are being tested in trial NCT06769022?
The interventions under investigation include: Goal Setting and Exercise Intensity Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT06769022?
This trial is sponsored by University of Colorado, Boulder, which has 69 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06769022 being conducted?
This trial has 3 study locations across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cognitive Decline
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06769022's enrollment target sits among peer trials
20 59th of 61 higher than 1 of 61 other Cognitive Decline trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cognitive Decline trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
δ in Dementia Clinical Trials
RECRUITING · NA
-
mPATH for Low-income Older Adults
RECRUITING · NA
-
MindWalk Intervention for Older South Asian Caregivers of People With Cognitive Disabilities (CD)
RECRUITING · NA
-
Preventing Cognitive Decline by Reducing BP Target Trial
RECRUITING · NA
-
Essential Fats For Enhancing Cognitive Thinking (EFFECT) Study
RECRUITING · NA
-
Exercise Adherence and Cognitive Decline: Phase 2
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI